Study Design: A, multinational, double blind, placebo-controlled pilot RCT involving 80
patients in the general ICUs of 30 centres. Most patients will be recruited from within
Canada; however cases will be recruited from international sites. This study will be
conducted under the auspices of the Canadian Critical Care Trials Group (CCCTG) and the
International Forum for Acute Care Trialists (InFACT).
Phase:
Phase 2
Details
Lead Sponsor:
Canadian Critical Care Trials Group
Collaborators:
Canadian Institutes of Health Research (CIHR) Public Health Agency of Canada (PHAC) The Physicians' Services Incorporated Foundation